| Balance Sheet Details |
3. Balance Sheet Details
Prepaid Expenses and Other Current Assets
Prepaid expenses and other current assets consisted
of the following:
| | |
March 31,
2025 | | |
December 31,
2024 | |
| Prepaid insurance costs | |
$ | 95,012 | | |
$ | 17,198 | |
| Other prepaid expenses & current assets | |
| 128,258 | | |
| 49,501 | |
| Total prepaid expenses & current assets | |
$ | 223,270 | | |
$ | 66,699 | |
Accrued Expenses
Accrued expenses consisted of the following:
| | |
March 31,
2025 | | |
December 31,
2024 | |
| Accrued payroll and related expenses | |
$ | 217,967 | | |
$ | 835,724 | |
| Accrued clinical study expenses | |
| 236,168 | | |
| 183,824 | |
| Accrued professional fees | |
| — | | |
| 67,049 | |
| Accrued clinical development costs | |
| — | | |
| 41,203 | |
| Accrued other expenses | |
| 9,497 | | |
| — | |
| Total accrued expenses | |
$ | 463,632 | | |
$ | 1,127,800 | |
|
3. Balance Sheet Details
Prepaid Expenses and Other Current Assets
Prepaid expenses and other
current assets consisted of the following:
| | |
December 31,
2024 | | |
December 31,
2023 | |
| Prepaid insurance costs | |
$ | 17,198 | | |
$ | 55,215 | |
| Other prepaid expenses & current assets | |
| 49,501 | | |
| 29,476 | |
| Total prepaid expenses & current assets | |
$ | 66,699 | | |
$ | 84,691 | |
Property and Equipment, Net
Property and equipment, net
consisted of the following:
| | |
December 31,
2024 | | |
December 31,
2023 | |
| Lab equipment | |
$ | 151,134 | | |
$ | 131,963 | |
| Total property and equipment, gross | |
| 151,134 | | |
| 131,963 | |
| Accumulated depreciation | |
| (94,802 | ) | |
| (66,879 | ) |
| Total property and equipment, net | |
$ | 56,332 | | |
$ | 65,084 | |
Depreciation expense was $27,923
for year ended December 31, 2024 and $25,049 for the year ended December 31, 2023.
Accrued Expenses
Accrued expenses consisted
of the following:
| | |
December 31,
2024 | | |
December 31,
2023 | |
| Accrued payroll and related expenses | |
$ | 835,724 | | |
$ | 768,720 | |
| Accrued clinical study expenses | |
| 183,824 | | |
| 10,268 | |
| Accrued professional fees | |
| 67,049 | | |
| 219,888 | |
| Accrued clinical development costs | |
| 41,203 | | |
| 153,584 | |
| Total accrued expenses | |
$ | 1,127,800 | | |
$ | 1,152,460 | |
|